Simulation of the dosing regimen of the anti-MRSA drug daptomycin in a patient receiving thrice-weekly hemodialysis: Is it reasonable to administer 1.5 times dosage before the 72-hour interval after dialysis?

Abe, J., Yamada, K., Yoshii, N., Shibata, W., Oshima, K., & Kakeya, H. (2020). Simulation of the dosing regimen of the anti-MRSA drug daptomycin in a patient receiving thrice-weekly hemodialysis: Is it reasonable to administer 1.5 times dosage before the 72-hour interval after dialysis? Japanese Journal of Clinical Pharmacology and Therapeutics, 51(6), 325–330. https://doi.org/10.3999/JSCPT.51.325